|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
45,766,000 |
Market
Cap: |
1.23(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$6.29 - $33.79 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8 |
Insider 3/6 Months : 8.6 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
11,700 |
11,700 |
11,700 |
Total Buy Value |
$0 |
$198,783 |
$198,783 |
$198,783 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
0 |
27,257 |
39,770 |
602,067 |
Total Sell Value |
$0 |
$483,218 |
$738,499 |
$28,445,866 |
Total People Sold |
0 |
5 |
6 |
8 |
Total Sell Transactions |
0 |
6 |
12 |
58 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rogers Erica J. |
President and CEO |
|
2023-01-11 |
4 |
AS |
$51.53 |
$309,180 |
D/D |
(6,000) |
246,199 |
|
-41% |
|
Rogers Erica J. |
President and CEO |
|
2023-01-11 |
4 |
OE |
$1.60 |
$9,600 |
D/D |
6,000 |
252,199 |
|
- |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2023-01-03 |
4 |
AS |
$52.87 |
$357,031 |
D/D |
(6,753) |
98,205 |
|
-27% |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2023-01-03 |
4 |
OE |
$1.60 |
$15,744 |
D/D |
6,753 |
99,783 |
|
- |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-12-15 |
4 |
OE |
$1.60 |
$24,000 |
D/D |
15,000 |
191,527 |
|
- |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-12-13 |
4 |
AS |
$55.00 |
$1,375,000 |
D/D |
(25,000) |
176,527 |
|
-21% |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-12-13 |
4 |
OE |
$1.60 |
$40,000 |
D/D |
25,000 |
201,527 |
|
- |
|
Chou Tony M. |
|
|
2022-12-13 |
4 |
AS |
$55.00 |
$553,300 |
D/D |
(10,060) |
88,715 |
|
-21% |
|
Rogers Erica J. |
President and CEO |
|
2022-12-12 |
4 |
AS |
$53.85 |
$538,501 |
D/D |
(10,000) |
246,199 |
|
-15% |
|
Rogers Erica J. |
President and CEO |
|
2022-12-12 |
4 |
OE |
$1.60 |
$16,000 |
D/D |
10,000 |
256,199 |
|
- |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-12-01 |
4 |
AS |
$53.00 |
$357,909 |
D/D |
(6,753) |
98,205 |
|
-23% |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-12-01 |
4 |
OE |
$1.46 |
$10,457 |
D/D |
6,753 |
102,472 |
|
- |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-11-11 |
4 |
AS |
$50.00 |
$1,240,000 |
D/D |
(24,800) |
176,527 |
|
-21% |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-11-11 |
4 |
OE |
$1.60 |
$39,680 |
D/D |
24,800 |
201,327 |
|
- |
|
Rogers Erica J. |
President and CEO |
|
2022-11-11 |
4 |
AS |
$50.03 |
$500,309 |
D/D |
(10,000) |
246,199 |
|
-21% |
|
Rogers Erica J. |
President and CEO |
|
2022-11-11 |
4 |
OE |
$1.60 |
$16,000 |
D/D |
10,000 |
256,199 |
|
- |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-11-09 |
4 |
AS |
$50.00 |
$10,000 |
D/D |
(200) |
176,527 |
|
-14% |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-11-09 |
4 |
OE |
$1.60 |
$320 |
D/D |
200 |
176,727 |
|
- |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-11-01 |
4 |
AS |
$44.17 |
$298,280 |
D/D |
(6,753) |
98,205 |
|
-4% |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-11-01 |
4 |
OE |
$1.46 |
$9,859 |
D/D |
6,753 |
104,958 |
|
- |
|
Rogers Erica J. |
President and CEO |
|
2022-10-11 |
4 |
AS |
$42.32 |
$423,218 |
D/D |
(10,000) |
246,199 |
|
23% |
|
Rogers Erica J. |
President and CEO |
|
2022-10-11 |
4 |
OE |
$1.60 |
$16,000 |
D/D |
10,000 |
256,199 |
|
- |
|
Buchanan Lucas W. |
COO/CFO |
|
2022-10-04 |
4 |
D |
$47.86 |
$124,048 |
D/D |
(2,592) |
176,527 |
|
- |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-10-03 |
4 |
AS |
$44.76 |
$302,264 |
D/D |
(6,753) |
98,205 |
|
8% |
|
Davis Andrew S. |
Chief Commercial Officer |
|
2022-10-03 |
4 |
OE |
$1.46 |
$9,859 |
D/D |
6,753 |
104,958 |
|
- |
|
410 Records found
|
|
Page 4 of 17 |
|
|